BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32517967)

  • 1. Validation of a European Spanish-version of the Self-Evaluation of Negative Symptoms (SNS) in patients with schizophrenia.
    García-Álvarez L; Martínez-Cao C; Bobes-Bascarán T; Portilla A; Courtet P; de la Fuente-Tomás L; Velasco Á; González-Blanco L; Zurrón-Madera P; Fonseca-Pedrero E; Sáiz PA; García-Portilla MP; Bobes J
    Rev Psiquiatr Salud Ment (Engl Ed); 2020 Jun; ():. PubMed ID: 32517967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of a European Spanish-version of the Self-Evaluation of Negative Symptoms (SNS) in patients with schizophrenia.
    García-Álvarez L; Martínez-Cao C; Bobes-Bascarán T; Portilla A; Courtet P; de la Fuente-Tomás L; Velasco Á; González-Blanco L; Zurrón-Madera P; Fonseca-Pedrero E; Sáiz PA; García-Portilla MP; Bobes J
    Rev Psiquiatr Salud Ment (Engl Ed); 2022; 15(1):14-21. PubMed ID: 35256068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of a European Spanish adaptation of the Apathy Evaluation Scale-self-rated version (AES-S) in patients with schizophrenia.
    Martínez-Cao C; García-Álvarez L; Bobes-Bascarán T; de la Fuente-Tomás L; Fernández-Egea E; Velasco Á; González-Blanco L; Zurrón-Madera P; Fonseca-Pedrero E; Sáiz-Martínez PA; García-Portilla MP; Bobes J
    Rev Psiquiatr Salud Ment (Engl Ed); 2022; 15(1):22-28. PubMed ID: 35256069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of a European Spanish adaptation of the Apathy Evaluation Scale-self-rated version (AES-S) in patients with schizophrenia.
    Martínez-Cao C; García-Álvarez L; Bobes-Bascarán T; de la Fuente-Tomás L; Fernández-Egea E; Velasco Á; González-Blanco L; Zurrón-Madera P; Fonseca-Pedrero E; Sáiz-Martínez PA; García-Portilla MP; Bobes J
    Rev Psiquiatr Salud Ment (Engl Ed); 2020 Jun; ():. PubMed ID: 32507728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spanish Validation of the MAP-SR: Two Heads Better Than One for the Assessment of Negative Symptoms of Schizophrenia.
    García-Portilla MP; García-Álvarez L; de la Fuente-Tomás L; Dal Santo F; Velasco A; González-Blanco L; Zurrón-Madera P; Fonseca-Pedrero E; Bobes-Bascarán MT; Sáiz PA; Bobes J
    Psicothema; 2021 Aug; 33(3):473-480. PubMed ID: 34297678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Validation of the French version of the self-evaluation of negative symptoms (SNS)].
    Hervochon C; Bourgeois V; Rotharmel M; Duboc JB; Le Goff B; Quesada P; Campion D; Dollfus S; Guillin O
    Encephale; 2018 Dec; 44(6):512-516. PubMed ID: 29195803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spanish validation of the Negative Symptom Assessment-16 (NSA-16) in patients with schizophrenia.
    Garcia-Alvarez L; Garcia-Portilla MP; Saiz PA; Fonseca-Pedrero E; Bobes-Bascaran MT; Gomar J; Muñiz J; Bobes J
    Rev Psiquiatr Salud Ment (Engl Ed); 2018; 11(3):169-175. PubMed ID: 29628403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polish version of the Self-evaluation of Negative Symptoms (SNS).
    Wójciak P; Górna K; Domowicz K; Jaracz K; Szpalik R; Michalak M; Rybakowski J
    Psychiatr Pol; 2019 Jun; 53(3):551-559. PubMed ID: 31522196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing negative symptoms in schizophrenia: Validity of the clinical assessment interview for negative symptoms in Singapore.
    Rekhi G; Ang MS; Yuen CKY; Ng WY; Lee J
    Schizophr Res; 2019 Apr; 206():177-182. PubMed ID: 30558979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validity and Reliability Study of Turkish Version of Clinical Assessment Interview for Negative Symptoms (CAINS).
    Vayisoğlu S; Karahan S; Gürel ŞC; Yağcioğlu AEA
    Noro Psikiyatr Ars; 2024; 61(1):59-65. PubMed ID: 38496217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European Validation of the Self-Evaluation of Negative Symptoms (SNS): A Large Multinational and Multicenter Study.
    Dollfus S; Mucci A; Giordano GM; Bitter I; Austin SF; Delouche C; Erfurth A; Fleischhacker WW; Movina L; Glenthøj B; Gütter K; Hofer A; Hubenak J; Kaiser S; Libiger J; Melle I; Nielsen MØ; Papsuev O; Rybakowski JK; Sachs G; Üçok A; Brando F; Wojciak P; Galderisi S
    Front Psychiatry; 2022; 13():826465. PubMed ID: 35173641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Turkish version of the self-evaluation of negative symptoms scale (SNS).
    Polat I; Ince Guliyev E; Elmas S; Karakaş S; Aydemir Ö; Üçok A
    Int J Psychiatry Clin Pract; 2022 Sep; 26(3):221-227. PubMed ID: 35700173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the lithuanian version of the self-evaluation of negative symptoms scale (SNS).
    Montvidas J; Adomaitienė V; Leskauskas D; Dollfus S
    Nord J Psychiatry; 2021 Jul; 75(5):351-355. PubMed ID: 33356749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the Spanish Personal and Social Performance scale (PSP) in outpatients with stable and unstable schizophrenia.
    Garcia-Portilla MP; Saiz PA; Bousoño M; Bascaran MT; Guzmán-Quilo C; Bobes J;
    Rev Psiquiatr Salud Ment; 2011 Jan; 4(1):9-18. PubMed ID: 23446097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The psychometric properties of the Self-Evaluation of Negative Symptoms Scale (SNS) in treatment-resistant schizophrenia (TRS).
    Goldring A; Borne S; Hefner A; Thanju A; Khan A; Lindenmayer JP
    Schizophr Res; 2020 Oct; 224():159-166. PubMed ID: 33071071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the Spanish version of the Clinical Assessment for Negative Symptoms (CAINS).
    Valiente-Gómez A; Mezquida G; Romaguera A; Vilardebò I; Andrés H; Granados B; Larrubia J; Pomarol-Clotet E; McKenna PJ; Sarró S; Bernardo M
    Schizophr Res; 2015 Aug; 166(1-3):104-9. PubMed ID: 26116328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring negative symptoms in patients with schizophrenia: reliability and validity of the Korean version of the Motivation and Pleasure Scale-Self-Report.
    Kim JS; Jang SK; Park SC; Yi JS; Park JK; Lee JS; Choi KH; Lee SH
    Neuropsychiatr Dis Treat; 2016; 12():1167-72. PubMed ID: 27274251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for negative symptoms: preliminary results from the self-report version of the Clinical Assessment Interview for Negative Symptoms.
    Park SG; Llerena K; McCarthy JM; Couture SM; Bennett ME; Blanchard JJ
    Schizophr Res; 2012 Mar; 135(1-3):139-43. PubMed ID: 22265640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative Symptom Inventory-Self-Report (NSI-SR): Initial development and validation.
    Raugh IM; Luther L; Bartolomeo LA; Gupta T; Ristanovic I; Pelletier-Baldelli A; Mittal VA; Walker EF; Strauss GP
    Schizophr Res; 2023 Jun; 256():79-87. PubMed ID: 37172500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Motivation and Pleasure Scale-Self-Report (MAP-SR): reliability and validity of a self-report measure of negative symptoms.
    Llerena K; Park SG; McCarthy JM; Couture SM; Bennett ME; Blanchard JJ
    Compr Psychiatry; 2013 Jul; 54(5):568-74. PubMed ID: 23351831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.